{"ticker": {"uuid": "3bc01bec-3b89-43d1-b956-3676b3c6bd53", "symbol": "ATH", "name": "Alterity Therapeutics Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Here's Why We're Not Too Worried About Alterity Therapeutics' (ASX:ATH) Cash Burn Situation", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-16T23:17:53+00:00", "published_display": "16 Jun 2026 23:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics Ltd Warrant 2023-31.08.26 on Alterity/Deferred Delivery Statistics \u2013 ASX:ATHDB", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQZWNMV0x4WVBfc2VmVVFZTXEyTnNPT1l3RG40b1drVU9rcHMzWnQ5bzRMVU04QXBHaFhDcmFqbDIzeEZWa0pRNW0tcU5lUzR5N3NEc1ZRY3J5Rm83U2RVMDZ0c29FVFpEYVplenV3ajdUNnpkelRGZlNBSUlrdjE2cmtCRHlGZw?oc=5", "source_name": "TradingView", "published_at": "2026-06-10T13:14:36+00:00", "published_display": "10 Jun 2026 13:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics (ATHE) completes 1-for-50 share consolidation and trading reset", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOd0RrcTdFbU85SWQ1N0NCMnZNRXV6TktjQlhvQnJWSUZWMkJ4TVRLRHpoVjVXWGd2QW5ESmtjR195dnI3eGFoZjNzSS1Kc2xvOG9fQXZoUmE0Nm4xM1o4Z183QnplZWZER0hxZHJsMkMxRXF1NDhRY1lwWm9HVFVPT0ZEb3Z6bEU5YjI4T3daNnRnMmd6dWx3LUxlNUh4ZzF6QXBIcFgyS3R1Ql9MZUhFNFktM0VsZEFEWnhaSFlB?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Consolidates Shares and Temporarily Changes ASX Ticker Ahead of Phase 3 Push", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxOWFNUSWFTSFJoQkdyVUZDNE1SSHdUS3Z5Y25PRnlVeFNILThYcWtDUEJsTmwzVUloMnlzUnZXRnp0anlvREZSVzJnOWJvbkFuSTdDa3ZKYmxrNkhkTzFKUDNzOGc4S1Y4Qks1WmFVeXBmS3c4dU5qNkxEeS1zcmhXQXVLV0JFVUMxNzBvNl9TcE9CVVR2X1lHUEpkUVlFazlqZ3ZZR2FCUVpXRW9HbFduNlVNWUJ0R055UVlaUTFRVkhLb1pUUUpRTVU2TkphMFVsSFlqWkNoVjAyS0RNYWxGejVMSDFudmtOSW5yc1VzYWtEdkt4MDA0MjgzV05Da3ly?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics (ASX:ATH) Holds Steady \u2014 What Investors Are Watching?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOQjh6NXlqNFhzQUhqWE1fekNud0hYa2xKeHpadFprUVRUSGl2V2kxcE5QbVppcTZmRTJqWWdNUGJpZ2VMMmo5enRIZGNNMmc2T3FCU3pMRjFHMmdwMlR6NV90Mks0YzVNS29vRDZxWEZqSWl1UzdaTHU3OTBpZ0xuTEZMcU00eWVISWFoV205T0Y5aUtYUjJuN01IMU5MRjBMQ0plT0VMUG8xbnY4RnlR?oc=5", "source_name": "Kalkine", "published_at": "2026-05-27T07:10:00+00:00", "published_display": "27 May 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Three cities, one MSA program: Alterity lines up May presentations", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNcHlNS3IxVERjRGk4VHFTNkFPb3pxZGVLME9oZjN4Wm02T0l5Zml2M0RhaUFYNXk1MExCUUI2YWtYTkVBb1gyUXVVWGRKZm9FNGxyazRyYllQYUgwMUpnLWwxZ2dnVXptWnBFbHNyNnVaT3Y2aEhMeHE5RDhHc1M5bGFEeUV2c3pKYUZpMEtfaGRXWml1Z1hXam5GMEJOd0F3TTN0ZmdSNHFITllTSG5WdWtJMjZnWVBIVDJHUnFR?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "StockTake: Alterity Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxQMWZsYUVsYktpVXdPU1Q4b3RVejVrTWlvNmtWVjYzZE0zTEdiRGJYSm16NS1aY1RJM3ZlRVdUbkw3TWJGcEpZaHNMZ1QycnpVUFZIU0Zva1N0Q1ZZNjI2YXNGdUU4dm8tRld3OXp5LXdFb0RLck9mRzlGV2R5TVlKeE1nUE9NcWdOY0ptQVdnaGh1TV9HLS1JMms2OWxBbmcxTW9CZDRkMkxUZkNTZWdLb0VFVXV0N2ZCZVNCYTZoWjloOXc1R0gzVmdhUXZaVmM1SU9WTENfQk81TTFINUtzR2ZuQWlVZ09FLWhlaTBLbGIyOTZKc3JkMEJn0gH_AUFVX3lxTE5zMTRVdDJoRDdYVHVQUXFnbW56UnNTT3E5bzFBaXFPeE9BajV2Nl9Ia1VpZnVTWjB0WEdjSVlpdVh1eU5fR1FETVZlWS14S0tQOUhraDU4a0FxbVFkMlE0c0pTREhmd2VvMU1aY2t6M1U5OFRseEI0QXcxV01YZUw1WkhrN3pIVjVVMkQwNDdXcXJMX0hldnM2am1RQ2xGd0VNTk1UYXBKRDd5QW1ZbmNIMWVaaHpxQzJsdXp5c1JCRlhVbnlXTzJiOTZlZ2wzX2JDYnc4M2h6RnFKWWpybkN2ZmhGb2hxQmZ3LVJsMmZwdU54MlBYWEVhck9VUFdNdw?oc=5", "source_name": "The Australian", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Who\u2019s Who: Alterity Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwJBVV95cUxQTDM1RElUSUVhVFBqWF93YXUzaGd0U2dGOFBPUzhCakl6SlE3cmpyakI3VU1jRHJ1Q0pGSUxHN0FKYVNZU1FURWhhTjFVUmpHemE1T3BuNktfMm9XUTQ0RmpIRnRBbUZFQ2pvaHVVOG50VGdhWUlfMWYtWk1ZVEZiWjYwMkpBU09zRmhZZlNiVm1pVFM1T2xQWHhhMGFTMTAxLXdVSFlqSk9oa0w2VXlsQzdWSjNxSHNHcUVBMjlZZEtmQVN4T2NaOHViNEZmOW1ZVmpibXItRGtCc2pHbHAtMlh5SDAwd0ViRzFkQzI1Qno4eEpXUFQ0SllUOVhmZnFrTFY40gGIAkFVX3lxTE9yd1Rqa1ZWM3haazNtMlhPTVJwUmFEWFFOamJ6YVJmYmFaZkF4dm1rR1l1R1V4WjF2ZjlKdWVaY3pHSzk3Ujl1SmZ4LWZzMkRQU1laSi10OUM5U0Z1NVFBall5MTlXWGtmY1I5WEVpY2FJa2ZwVnRlZ1R1bFBPUnBOaC03ZFpFWVhSUkVCd18yVzk4aUg5Z3RTLUdVNG9USUkxOVZRMXo2NF91bmNMdG52RC1GQnJ5aHdJbjhJZWh3aGU3WjRqZmVwblpfczd0S1JlV0p0c0hrRFBGLVplTFd6SEcwZEVHaEtUc1NjcGJsVzdtSlRQU1FfSUJBcl9FU1o2U1R6RE1FRQ?oc=5", "source_name": "The Australian", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "When Can We Expect A Profit From Alterity Therapeutics Limited (ASX:ATH)?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-31T07:00:00+00:00", "published_display": "31 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Alterity Therapeutics (ASX:ATH) Can Easily Afford To Drive Business Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxONDlpR005NEtGUllyV0FnQkQ1QXFHbWhGVEI4MER0NGgybnlVcjZKRG9ORzlPWDVSNjdGbXY2QTN3b3p5TmEyQ0trOFhDTGNfMWtfcVBOR3M3V1lXODNxTVI5Y3JpRUdJd1hHZXlQVGFHZ2NZQUc2ZWc0c1F0UHF3VFp5RzBKYUFq?oc=5", "source_name": "Market source", "published_at": "2025-08-31T07:00:00+00:00", "published_display": "31 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics Raises About AU$2.1 Million Via US Facility; Shares Soar 17%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_gFBVV95cUxQV0tLenVjdnZPbElYTGNuNDFCZEVVNHZTNzdaUFlrVm9TMVB4ZzJMVnozeW80Q1EyVzg2ZkptRGM1bFhRbGpUakdSMlJOeklqTnhKR05pd0tidWI2UmFFQU52Qi1PTGVuRk5Semh6UU9FN1UxbkdfYjBLSnMwd2JpWVh5QnhlUkxCOGlEZXp6ME4yUUlDT3YzOXpneVl6TUV6QjJXQnN5ZEJIeTdqZGVJRWdzU1RveEtuRzV5U3lYckM2d19yZ1FINGRrejhEMTRlLUxYOXJVSzNHYW10c3RHZG5vbE9FaGZPa1liZHZoV0NnUGxON1JMVTVMYmdsdw?oc=5", "source_name": "marketscreener.com", "published_at": "2025-02-02T08:00:00+00:00", "published_display": "02 Feb 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics Ltd Company Profile & Introduction", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE5Eczk4RFNoTzByOFpweU5nSW5qcFprVmh1clZFMVpPRl85NkxycFhPc3VVVl9xNDZnbkY4YktNZ3pRcVBlOURraWhseHlqT1FfRld5aUZ3Vlg?oc=5", "source_name": "Moomoo", "published_at": "2024-09-04T07:00:00+00:00", "published_display": "04 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPcURraHdxemtkeXZoUV9YOGlyYUhuTTB0NmtscFExNVFEQ2lXSV9DbndLZUdIbTZBbUhnMm9yTHdMN1NTQ0NKXzgzSXZKeWtRQ0E5SUpYRlNFdVhPRmpsXzE2d2VpTW9BUFh4WVFOYzBnZ0lXLVVlRGxodGlNSUJWU0pRWklGV2c3VXh0SW1mLVNNTVpBNzBWR0V4NWdVS2dXVEdQLVoxWjlMT0JObURKUXQyYWtqaldGMXRmQnoyelYycDJlbkI0?oc=5", "source_name": "PR Newswire", "published_at": "2023-01-06T08:00:00+00:00", "published_display": "06 Jan 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics Limited (ASX: ATH) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNRU1RN3lZZVVUb1hDRVZZckJkaGp6bFJlZ2xWOVRkRlJFOTNNdXBtb1Zmcl9WT0otX1pKNXJMdzNLSkFWVzZpSi1yZUhnaE9Fek9vUFdVYkkwZGwycVRzNzRqZ05mWFlEQ1BGZk1CZG1yd3JvaGVfRUhXRjFXdE9rVnRVZEhWbF9jSGxvV3h4akd6bDZqNXlYM2stMA?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2020-02-05T03:14:47+00:00", "published_display": "05 Feb 2020 03:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics Limited (ASX:ATH) - Shares, Dividends & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxONlJOZFE4bnZ2S1lTWHJlNjhRMjBadzFMME9TX1hMT1ZiQmNjV0cwUjkwc1VqeEF2cERhNnNTbFNwLWY1cDhHbzVpZk1mbXJEc0FVZTY1ZDhrS2h1N0IwY2xaVGVzVjE3bTdKTHlpSTB0VW53WTkzOTdBbmJvYnRRRUVtV0tyY1lXTmVj?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-27T06:46:16+00:00", "published_display": "27 Sep 2019 06:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics Limited (ASX: ATH) - Announcements", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSllELUduRGpRbUlqQUI0RHh3aUFWeUhfVWZGRDFQemZhbUhyUTlOcFRfeDJ5RUZFSTNhX29tU2hlUlR1WkNyMS1NZ09EQjhBUE5HakFyeTBDUXh6V0szaGtiNEg0ZTI3NDBmdzczRTlOMXdSeS1EN3pqYnNRTXVhdlpGUVRUVDRXaXZ4UTFIa3ZST0NzM0U4czBWcE1Fdw?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-25T03:23:27+00:00", "published_display": "25 Sep 2019 03:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ATH Stock Price and Chart \u2014 ASX:ATH", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE52NDlVUFBJRENSRzRoMkd2TTVmSG93V2ZydFNRZWRiajV6a1QteFd6bXYyMFlxYTRmQzhLRnJmcVNNcmZUZXhDWldjTWpKNzhvNzZReUNoMA?oc=5", "source_name": "TradingView", "published_at": "2019-04-14T14:39:25+00:00", "published_display": "14 Apr 2019 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Here's Why We're Not Too Worried About Alterity Therapeutics' (ASX:ATH) Cash Burn Situation", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-16T23:17:53+00:00", "published_display": "16 Jun 2026 23:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics Ltd Warrant 2023-31.08.26 on Alterity/Deferred Delivery Statistics \u2013 ASX:ATHDB", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQZWNMV0x4WVBfc2VmVVFZTXEyTnNPT1l3RG40b1drVU9rcHMzWnQ5bzRMVU04QXBHaFhDcmFqbDIzeEZWa0pRNW0tcU5lUzR5N3NEc1ZRY3J5Rm83U2RVMDZ0c29FVFpEYVplenV3ajdUNnpkelRGZlNBSUlrdjE2cmtCRHlGZw?oc=5", "source_name": "TradingView", "published_at": "2026-06-10T13:14:36+00:00", "published_display": "10 Jun 2026 13:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics (ATHE) completes 1-for-50 share consolidation and trading reset", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOd0RrcTdFbU85SWQ1N0NCMnZNRXV6TktjQlhvQnJWSUZWMkJ4TVRLRHpoVjVXWGd2QW5ESmtjR195dnI3eGFoZjNzSS1Kc2xvOG9fQXZoUmE0Nm4xM1o4Z183QnplZWZER0hxZHJsMkMxRXF1NDhRY1lwWm9HVFVPT0ZEb3Z6bEU5YjI4T3daNnRnMmd6dWx3LUxlNUh4ZzF6QXBIcFgyS3R1Ql9MZUhFNFktM0VsZEFEWnhaSFlB?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Consolidates Shares and Temporarily Changes ASX Ticker Ahead of Phase 3 Push", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxOWFNUSWFTSFJoQkdyVUZDNE1SSHdUS3Z5Y25PRnlVeFNILThYcWtDUEJsTmwzVUloMnlzUnZXRnp0anlvREZSVzJnOWJvbkFuSTdDa3ZKYmxrNkhkTzFKUDNzOGc4S1Y4Qks1WmFVeXBmS3c4dU5qNkxEeS1zcmhXQXVLV0JFVUMxNzBvNl9TcE9CVVR2X1lHUEpkUVlFazlqZ3ZZR2FCUVpXRW9HbFduNlVNWUJ0R055UVlaUTFRVkhLb1pUUUpRTVU2TkphMFVsSFlqWkNoVjAyS0RNYWxGejVMSDFudmtOSW5yc1VzYWtEdkt4MDA0MjgzV05Da3ly?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics (ASX:ATH) Holds Steady \u2014 What Investors Are Watching?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOQjh6NXlqNFhzQUhqWE1fekNud0hYa2xKeHpadFprUVRUSGl2V2kxcE5QbVppcTZmRTJqWWdNUGJpZ2VMMmo5enRIZGNNMmc2T3FCU3pMRjFHMmdwMlR6NV90Mks0YzVNS29vRDZxWEZqSWl1UzdaTHU3OTBpZ0xuTEZMcU00eWVISWFoV205T0Y5aUtYUjJuN01IMU5MRjBMQ0plT0VMUG8xbnY4RnlR?oc=5", "source_name": "Kalkine", "published_at": "2026-05-27T07:10:00+00:00", "published_display": "27 May 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Three cities, one MSA program: Alterity lines up May presentations", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNcHlNS3IxVERjRGk4VHFTNkFPb3pxZGVLME9oZjN4Wm02T0l5Zml2M0RhaUFYNXk1MExCUUI2YWtYTkVBb1gyUXVVWGRKZm9FNGxyazRyYllQYUgwMUpnLWwxZ2dnVXptWnBFbHNyNnVaT3Y2aEhMeHE5RDhHc1M5bGFEeUV2c3pKYUZpMEtfaGRXWml1Z1hXam5GMEJOd0F3TTN0ZmdSNHFITllTSG5WdWtJMjZnWVBIVDJHUnFR?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "StockTake: Alterity Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-gFBVV95cUxQMWZsYUVsYktpVXdPU1Q4b3RVejVrTWlvNmtWVjYzZE0zTEdiRGJYSm16NS1aY1RJM3ZlRVdUbkw3TWJGcEpZaHNMZ1QycnpVUFZIU0Zva1N0Q1ZZNjI2YXNGdUU4dm8tRld3OXp5LXdFb0RLck9mRzlGV2R5TVlKeE1nUE9NcWdOY0ptQVdnaGh1TV9HLS1JMms2OWxBbmcxTW9CZDRkMkxUZkNTZWdLb0VFVXV0N2ZCZVNCYTZoWjloOXc1R0gzVmdhUXZaVmM1SU9WTENfQk81TTFINUtzR2ZuQWlVZ09FLWhlaTBLbGIyOTZKc3JkMEJn0gH_AUFVX3lxTE5zMTRVdDJoRDdYVHVQUXFnbW56UnNTT3E5bzFBaXFPeE9BajV2Nl9Ia1VpZnVTWjB0WEdjSVlpdVh1eU5fR1FETVZlWS14S0tQOUhraDU4a0FxbVFkMlE0c0pTREhmd2VvMU1aY2t6M1U5OFRseEI0QXcxV01YZUw1WkhrN3pIVjVVMkQwNDdXcXJMX0hldnM2am1RQ2xGd0VNTk1UYXBKRDd5QW1ZbmNIMWVaaHpxQzJsdXp5c1JCRlhVbnlXTzJiOTZlZ2wzX2JDYnc4M2h6RnFKWWpybkN2ZmhGb2hxQmZ3LVJsMmZwdU54MlBYWEVhck9VUFdNdw?oc=5", "source_name": "The Australian", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Who\u2019s Who: Alterity Therapeutics", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "When Can We Expect A Profit From Alterity Therapeutics Limited (ASX:ATH)?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-31T07:00:00+00:00", "published_display": "31 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Alterity Therapeutics (ASX:ATH) Can Easily Afford To Drive Business Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxONDlpR005NEtGUllyV0FnQkQ1QXFHbWhGVEI4MER0NGgybnlVcjZKRG9ORzlPWDVSNjdGbXY2QTN3b3p5TmEyQ0trOFhDTGNfMWtfcVBOR3M3V1lXODNxTVI5Y3JpRUdJd1hHZXlQVGFHZ2NZQUc2ZWc0c1F0UHF3VFp5RzBKYUFq?oc=5", "source_name": "Market source", "published_at": "2025-08-31T07:00:00+00:00", "published_display": "31 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics Raises About AU$2.1 Million Via US Facility; Shares Soar 17%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_gFBVV95cUxQV0tLenVjdnZPbElYTGNuNDFCZEVVNHZTNzdaUFlrVm9TMVB4ZzJMVnozeW80Q1EyVzg2ZkptRGM1bFhRbGpUakdSMlJOeklqTnhKR05pd0tidWI2UmFFQU52Qi1PTGVuRk5Semh6UU9FN1UxbkdfYjBLSnMwd2JpWVh5QnhlUkxCOGlEZXp6ME4yUUlDT3YzOXpneVl6TUV6QjJXQnN5ZEJIeTdqZGVJRWdzU1RveEtuRzV5U3lYckM2d19yZ1FINGRrejhEMTRlLUxYOXJVSzNHYW10c3RHZG5vbE9FaGZPa1liZHZoV0NnUGxON1JMVTVMYmdsdw?oc=5", "source_name": "marketscreener.com", "published_at": "2025-02-02T08:00:00+00:00", "published_display": "02 Feb 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics Ltd Company Profile & Introduction", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE5Eczk4RFNoTzByOFpweU5nSW5qcFprVmh1clZFMVpPRl85NkxycFhPc3VVVl9xNDZnbkY4YktNZ3pRcVBlOURraWhseHlqT1FfRld5aUZ3Vlg?oc=5", "source_name": "Moomoo", "published_at": "2024-09-04T07:00:00+00:00", "published_display": "04 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation)", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPcURraHdxemtkeXZoUV9YOGlyYUhuTTB0NmtscFExNVFEQ2lXSV9DbndLZUdIbTZBbUhnMm9yTHdMN1NTQ0NKXzgzSXZKeWtRQ0E5SUpYRlNFdVhPRmpsXzE2d2VpTW9BUFh4WVFOYzBnZ0lXLVVlRGxodGlNSUJWU0pRWklGV2c3VXh0SW1mLVNNTVpBNzBWR0V4NWdVS2dXVEdQLVoxWjlMT0JObURKUXQyYWtqaldGMXRmQnoyelYycDJlbkI0?oc=5", "source_name": "PR Newswire", "published_at": "2023-01-06T08:00:00+00:00", "published_display": "06 Jan 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics Limited (ASX: ATH) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNRU1RN3lZZVVUb1hDRVZZckJkaGp6bFJlZ2xWOVRkRlJFOTNNdXBtb1Zmcl9WT0otX1pKNXJMdzNLSkFWVzZpSi1yZUhnaE9Fek9vUFdVYkkwZGwycVRzNzRqZ05mWFlEQ1BGZk1CZG1yd3JvaGVfRUhXRjFXdE9rVnRVZEhWbF9jSGxvV3h4akd6bDZqNXlYM2stMA?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2020-02-05T03:14:47+00:00", "published_display": "05 Feb 2020 03:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics Limited (ASX:ATH) - Shares, Dividends & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxONlJOZFE4bnZ2S1lTWHJlNjhRMjBadzFMME9TX1hMT1ZiQmNjV0cwUjkwc1VqeEF2cERhNnNTbFNwLWY1cDhHbzVpZk1mbXJEc0FVZTY1ZDhrS2h1N0IwY2xaVGVzVjE3bTdKTHlpSTB0VW53WTkzOTdBbmJvYnRRRUVtV0tyY1lXTmVj?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-27T06:46:16+00:00", "published_display": "27 Sep 2019 06:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alterity Therapeutics Limited (ASX: ATH) - Announcements", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSllELUduRGpRbUlqQUI0RHh3aUFWeUhfVWZGRDFQemZhbUhyUTlOcFRfeDJ5RUZFSTNhX29tU2hlUlR1WkNyMS1NZ09EQjhBUE5HakFyeTBDUXh6V0szaGtiNEg0ZTI3NDBmdzczRTlOMXdSeS1EN3pqYnNRTXVhdlpGUVRUVDRXaXZ4UTFIa3ZST0NzM0U4czBWcE1Fdw?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-25T03:23:27+00:00", "published_display": "25 Sep 2019 03:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ATH Stock Price and Chart \u2014 ASX:ATH", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE52NDlVUFBJRENSRzRoMkd2TTVmSG93V2ZydFNRZWRiajV6a1QteFd6bXYyMFlxYTRmQzhLRnJmcVNNcmZUZXhDWldjTWpKNzhvNzZReUNoMA?oc=5", "source_name": "TradingView", "published_at": "2019-04-14T14:39:25+00:00", "published_display": "14 Apr 2019 14:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 78, "total_relevant": 17, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 14, "score": 53, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 91, "events": [{"event": "general", "label": "Market update", "weight": 8.25, "count": 15}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.6, "latest_week": "2026-06-19", "one_week_move": 21.2, "four_week_move": 20.0, "twelve_week_move": 50.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.804516, "market_dynamics_buy_signal": false, "relative_strength": 16.94612, "fair_value_gap": 58.1, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 26.6471, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+21.2% over one week, +20.0% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "intelligentinvestor.com.au", "count": 3}, {"label": "simplywall.st", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "Stock Titan", "count": 2}, {"label": "The Australian", "count": 2}, {"label": "The Globe and Mail", "count": 1}, {"label": "Kalkine", "count": 1}, {"label": "Market source", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 17}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 15}, {"label": "Balance sheet", "count": 1}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "91/100 classification confidence."}, {"label": "Company focus", "value": "17", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+21.2% over one week, +20.0% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Here's Why We're Not Too Worried About Alterity Therapeutics' (ASX:ATH) Cash Burn Situation"}], "updated_at": "2026-06-22T19:48:56.799399+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}